These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3740837)

  • 1. Metabolic mechanism of the anorectic and leptogenic effects of the serotonin agonist fenfluramine.
    Even P; Nicolaïdis S
    Appetite; 1986; 7 Suppl():141-63. PubMed ID: 3740837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextrofenfluramine increases energy cost of muscular effort.
    Even P; Nicolaidis S
    Pharmacol Biochem Behav; 1986 Mar; 24(3):647-55. PubMed ID: 3703900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dexfenfluramine on body weight set-point: study in the rat with hoarding behaviour.
    Fantino M; Faion F; Rolland Y
    Appetite; 1986; 7 Suppl():115-26. PubMed ID: 3740836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipostatic and ischymetric mechanisms originate dexfenfluramine-induced anorexia.
    Even P; Coulaud H; Nicolaïdis S
    Pharmacol Biochem Behav; 1988 May; 30(1):89-99. PubMed ID: 3174758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of normal food intake in rats and dogs and inhibition of experimentally induced hyperphagia in rats by CM 57373 and fenfluramine.
    Miranda GF; Poggesi E; Bianchetti A; Unkovic J; Samanin R
    Eur J Pharmacol; 1988 May; 150(1-2):155-61. PubMed ID: 2456940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms.
    Garattini S; Samanin R
    Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the anorectic actions of 5-HTP and fenfluramine.
    Fletcher PJ; Burton MJ
    Psychopharmacology (Berl); 1986; 89(2):216-20. PubMed ID: 3088639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.
    Goodall EM; Cowen PJ; Franklin M; Silverstone T
    Psychopharmacology (Berl); 1993; 112(4):461-6. PubMed ID: 7871058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of fenfluramine and other anorectic agents in different feeding and drinking paradigms in rats.
    Rowland NE; Antelman SM; Bartness TJ
    Life Sci; 1985 Jun; 36(24):2295-300. PubMed ID: 4010458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy expenditure and substrate oxidation rates of obese rats during a 12-day treatment with dexfenfluramine.
    Boschmann M; Aust L; Frenz U; Noack R
    Ann Nutr Metab; 1996; 40(1):10-23. PubMed ID: 8722302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between metabolic and behavioral effects of dexfenfluramine treatment.
    Even P; Coulaud H; Aucouturier JL; Nicolaidis S
    Clin Neuropharmacol; 1988; 11 Suppl 1():S93-6. PubMed ID: 3180112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anorectic drugs and prior feeding on food-rewarded runway behavior.
    Thurlby PL; Samanin R
    Pharmacol Biochem Behav; 1981 Jun; 14(6):799-804. PubMed ID: 7255515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine.
    Groppetti A; Parenti M; Dellavedova L; Tirone F
    J Pharmacol Exp Ther; 1984 Feb; 228(2):446-53. PubMed ID: 6694120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice.
    Arch JR
    Am J Clin Nutr; 1981 Dec; 34(12):2763-9. PubMed ID: 7315777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic fenfluramine treatment: effects on body weight, food intake and energy expenditure.
    Stallone DD; Levitsky DA
    Int J Obes Relat Metab Disord; 1994 Oct; 18(10):679-85. PubMed ID: 7866463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic consequences of fenfluramine for the control of body weight.
    Levitsky DA; Troiano R
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):167S-172S. PubMed ID: 1728828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral and central mechanisms of action of serotoninergic anorectic drugs.
    Carruba MO; Mantegazza P; Memo M; Missale C; Pizzi M; Spano PF
    Appetite; 1986; 7 Suppl():105-13. PubMed ID: 3740835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the thermic effect of food by d-fenfluramine.
    Levitsky DA; Stallone D
    Clin Neuropharmacol; 1988; 11 Suppl 1():S90-2. PubMed ID: 3180111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The time-structure of the anorectic effect of satietin.
    Sándor G; Knoll J
    Physiol Behav; 1985 May; 34(5):851-3. PubMed ID: 4034724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.